HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.
Source: precisiononcologynews.com